Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-01-27

FDA Approved: DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE — Original Application (Winder Laboratories LLC)

View source ↗

Summary

FDA approved the original application for a generic diphenoxylate hydrochloride and atropine sulfate product (ANDA 211362) from Winder Laboratories LLC for the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Diphenoxylate hydrochloride and atropine sulfate (Diphenoxylate hydrochloride and atropine sulfate)

Snippet

ORIG AP for DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE (DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE)